CPT1C and neoplasm: In CRC and other malignancies, ACSL1 augments mitochondrial FAO via the AMPK–Carnitine Palmitoyltransferase 1C (CPT1C)–ATP axis, thereby supporting both tumor cell proliferation and metastatic dissemination (252, 253).